Listing Page

Category: Uncategorized

FDA’s FY2025 Report on the State of Pharmaceutical Quality: What Inspection Trends Mean for API Sourcing
FDA released its FY2025 Report on the State of Pharmaceutical Quality in June, the agency’s annual assessment...
Read More >
The Rise of Obesity Drugs: What It Means for Pharmaceutical Supply Chains
Obesity drugs have quickly become one of the fastest-growing classes of medication in the pharmaceutical...
Read More >
Tariff Pressure on APIs: Key Changes Since Early 2025
Earlier in 2025, we examined how tariffs and trade policy were reshaping pharmaceutical supply chains...
Read More >